Serampore, India

Subhendu Mukherjee

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Disc Medicine, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Subhendu Mukherjee. Retrieved from https://idiyas.com/inventor/subhendu-mukherjee-br3acx8y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Subhendu Mukherjee: Innovator in Matriptase Inhibition

Introduction

Subhendu Mukherjee is a notable inventor based in Serampore, India. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit matriptase 2. His work is crucial for advancing therapeutic options in various medical applications.

Latest Patents

Mukherjee holds a patent for "Matriptase 2 inhibitors and uses thereof." This invention provides compounds designed to inhibit matriptase 2, or its mutants, along with compositions and methods for their use. This patent represents a significant advancement in the understanding and treatment of conditions related to matriptase 2.

Career Highlights

Currently, Subhendu Mukherjee is associated with Disc Medicine, Inc., where he continues to innovate and contribute to the field. His expertise in biochemistry and patentable inventions has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Mukherjee collaborates with esteemed colleagues such as Srikanth Venkatraman and Rajeev Goswami. Their combined efforts enhance the research and development initiatives at Disc Medicine, Inc.

Conclusion

Subhendu Mukherjee's work in matriptase inhibition exemplifies the impact of innovative research in medicine. His contributions are paving the way for new therapeutic strategies and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…